Rezultati - Eduardo SL Gonçales
- Showing 1 - 16 results of 16
-
1
-
2
-
3
Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil od Priscila A Tonetto, Neiva SL Gonçales, Viviane Cristina Fais, A.G. Vigani, Eduardo SL Gonçales, Adriana Feltrin, Fernando Lopes Gonçales
Izdano 2009Artigo -
4
-
5
-
6
-
7
-
8
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life? od Fernando Lopes Gonçales, Camila A Moma, A.G. Vigani, Adriana FCF Angerami, Eduardo SL Gonçales, Raquel Tozzo, Maria HP Pavan, Neiva SL Gonçales
Izdano 2010Artigo -
9
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors od N. Miotto, L.C. Mendes, L.P. Zanaga, Eduardo SL Gonçales, Mariana Lazarini, Marcelo N. Pedro, Fernando Lopes Gonçales, R.S.B. Stucchi, A.G. Vigani
Izdano 2016Artigo -
10
Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil od A.G. Vigani, Maria Helena Postal Pavan, Raquel Tozzo, Eduardo SL Gonçales, Adriana Feltrin, Viviane Cristina Fais, Maria SK Lazarini, Neiva SL Gonçales, Fernando Lopes Gonçales
Izdano 2008Artigo -
11
Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C od L.C. Mendes, Paulo Roberto Abrão Ferreira, N. Miotto, L.P. Zanaga, Eduardo SL Gonçales, Mariana Lazarini, Fernando Lopes Gonçales Júnior, R.S.B. Stucchi, A.G. Vigani
Izdano 2016Artigo -
12
All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response od N. Miotto, L.C. Mendes, L.P. Zanaga, Maria Silvia Kroll Lazarini, Eduardo SL Gonçales, Marcelo N. Pedro, Fernando Lopes Gonçales, R.S.B. Stucchi, A.G. Vigani
Izdano 2018Artigo -
13
-
14
Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3 od A.G. Vigani, Eduardo SL Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Cristina Fais, Adriana Feltrin, Neiva Sellan Lopes Gonçales, Fernando Lopes Gonçales
Izdano 2012Artigo -
15
Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3 od A.G. Vigani, Eduardo SL Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Cristina Fais, Adriana Feltrin, Neiva Sellan Lopes Gonçales, Fernando Lopes Gonçales
Izdano 2012Artigo -
16
Simultaneous Imaging of Lung Perfusion and Glucose Metabolism in COVID-19 Pneumonia od Celso Darío Ramos, Alins P. Fernandes, Stephan Pinheiro Macedo de Souza, Mariana Fujiwara, Natália Tobar, Sérgio San Juan Dertkigil, Maria Emília Seren Takahashi, Eduardo SL Gonçales, Plı́nio Trabasso, Denise Engelbrecht Zantut‐Wittmann
Izdano 2021Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Virus
Gastroenterology
Immunology
Hepatitis C
Hepatitis C virus
Ribavirin
Interferon
Virology
Biology
Cirrhosis
Alpha interferon
Chronic hepatitis
Cohort
Coronavirus disease 2019 (COVID-19)
Disease
Gene
Genotype
Infectious disease (medical specialty)
Medical microbiology
Pathology
Pegylated interferon
2019-20 coronavirus outbreak
Adverse effect
Betacoronavirus
Biochemistry
Biopsy
Biosimilar
Fibrosis